StockIQStockIQ.tech

Harrow, Inc. (HROW) Stock Analysis

--

Free AI-powered analysis and research for Harrow, Inc. stock

Sector: Healthcare

Full HROW report

Harrow, Inc. (HROW) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.

Analyze HROW Now β†’

πŸ“° Latest Update

Harrow (HROW) Expected to Beat Earnings Estimates: Should You Buy?

Harrow (HROW) is anticipated to report a quarterly earnings decline of 48.5% year-over-year, with expected earnings of $0.17 per share and revenues of $99.88 million, reflecting a 39.4% increase. Analysts have recently revised their EPS estimates upward, resulting in a positive Earnings ESP of +44.00%, suggesting a likelihood of beating consensus estimates. However, the stock's performance will also depend on management's commentary during the earnings call, scheduled for November 9.

Read full article β†’

History

People also watch

DHR
Danaher Corporation
--
LLY
Eli Lilly and Company
--
TMO
Thermo Fisher Scientific Inc.
--
ATYR
aTyr Pharma, Inc.
--
TVGN
Tevogen Bio Holdings Inc.
--